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Tumor suppressorRecQ family DNA helicases function in themaintenance of genome stability. Mice deﬁcient in RecQL5, one of ﬁve
RecQ helicases, show a cancer predisposition phenotype, suggesting that RecQL5 plays a tumor suppressor role.
RecQL5 interacts with Rad51, a key factor in homologous recombination (HR), and displaces Rad51 from Rad51-
single stranded DNA (ssDNA) ﬁlaments in vitro. However, the precise roles of RecQL5 in the cell remain elusive.
Here, we present evidence suggesting that RecQL5 is involved in DNA interstrand crosslink (ICL) repair. Chicken
DT40 RECQL5 gene knockout (KO) cells showed sensitivity to ICL-inducing agents such as cisplatin (CDDP) and
mitomycin C (MMC) and a higher number of chromosome aberrations in the presence of MMC than wild-type
cells. The phenotypes of RECQL5 KO cells resembled those of Fanconi anemia gene KO cells. Genetic analysis
using corresponding gene knockout cells showed that RecQL5 is involved in the FANCD1 (BRCA2)-dependent
ICL repair pathway in which Rad51-ssDNA ﬁlament formation is promoted by BRCA2. The disappearance but
not appearance of Rad51-foci was delayed in RECQL5 KO cells after MMC treatment. Deletion of Rad54, which
processes the Rad51-ssDNA ﬁlament in HR, in RECQL5 KO cells increased sensitivity to CDDP and further delayed
the disappearance of Rad51-foci, suggesting that RecQL5 and Rad54 have different effects on the Rad51-ssDNA
ﬁlament. Furthermore, the frequency and variation of CDDP-induced gene conversion at the immunoglobulin
locuswere increased inRECQL5KOcells. These results suggest that RecQL5plays a role in regulating the incidence
and quality of ICL-induced recombination.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Genetic information is stably maintained and accurately inherited
through a variety of cellular mechanisms aimed at preventing or
repairing DNA damage. The breakdown of genome stability or DNA re-
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ights reserved.senescence of cells. Examples of widely known genome instability dis-
eases are RecQ-associated syndromes and Fanconi anemia (FA).
The RecQ family of DNA helicases is highly conserved in evolution
and plays important roles in the maintenance of genome stability
[1,2]. In higher vertebrates, ﬁve RecQ helicases, RecQL1, BLM, WRN,
RecQL4, and RecQL5, have been identiﬁed. BLM,WRN, and RECQL4 are
the genes responsible for Bloom syndrome, Werner syndrome, and
Rothmund–Thomson syndrome, respectively, which are diseases char-
acterized by cancer predisposition and premature aging [3–5]. Although
a genetic disease caused by the RECQL5 defect has not been identiﬁed,
RECQL5 knockout (KO) mice show a cancer prone phenotype, suggest-
ing that RecQL5 functions as a tumor suppressor [6,7]. RecQL5 interacts
with PCNA and RNA polymerase II, which are involved in DNA replica-
tion and repair, and transcription [8,9]. Furthermore, RecQL5 directly
binds to Rad51 recombinase via a BRC variant (BRCv) repeat domain
1003Y. Hosono et al. / Biochimica et Biophysica Acta 1843 (2014) 1002–1012of RecQL5 [10] and disrupts the Rad51-single stranded DNA (ssDNA) in-
teraction in vitro [6,11]. RecQL5 suppresses sister chromatid exchange
(SCE) formation in the cell, and therefore acts as an anti-recombinase
in vivo [12,13]. RecQL5 has been suggested to be involved in DNA
double-strand break (DSB) processing and some aspects of DNA replica-
tion and transcription [14]. Despite accumulating information about
RecQL5, its cellular role, especially as a tumor suppressor, remains large-
ly elusive.
Besides RecQ-related genome instability diseases, FA is another
genome instability disease characterized by cancer predisposition,
progressive bone marrow failure, and developmental abnormalities
[15–18]. Cells lacking FA-related proteins show high sensitivity to
DNA interstrand crosslink (ICL) damage-inducing agents such as
cisplatin (CDDP) and mitomycin C (MMC). Sixteen genes have been
identiﬁed as FA responsible genes, and their gene products function in
the ICL repair pathway. Eight FA proteins (FANCA/B/C/E/F/G/L/M) and
other proteins form the FA core complex. In response to replication
stress during S phase, the FA core complex acts as an E3 ligase catalyzing
the monoubiquitination of the FANCI-FANCD2 (ID) complex, and the
monoubiquitinated-ID complex promotes downstream ICL repair reac-
tions [15]. By contrast, six FA genes (FANCD1, FANCJ, FANCN, FANCO,
FANCP, and FANCQ), which are also known as BRCA2, BRIP1, PALB2,
RAD51C, SLX4, and XPF, respectively, are not involved in the
monoubiquitination of the ID complex [16,19,20]. Among them,
BRCA2, PALB2, and Rad51C, which are important factors for homolo-
gous recombination (HR), function in the recruitment of Rad51 to
DNA damage sites and the formation of the Rad51-ssDNA ﬁlament
[16,21]. In vertebrate cells, FA proteins and several others, including
those involved in the replication checkpoint, nucleolytic incision,
translesion synthesis (TLS), and HR, function in a variety of stages of
ICL repair [15–18].
In the present study, analyses performed using various gene knock-
out DT40 cells suggested that RecQL5 is involved in FANCD1 (BRCA2)-
dependent ICL repair and functions after the formation of the Rad51-
ﬁlament by BRCA2, independently of another regulator of Rad51,
Rad54. Loss of RecQL5 increased not only the frequency but also the var-
iation of immunoglobulin gene conversion associatedwith ICL-inducing
agents. The possible function of RecQL5 in regulating the quantity and
quality of recombination resulting in tumor suppression in vivowill be
discussed.
2. Materials and methods
2.1. Cell culture, DNA transfection, and RT-PCR
The chickenDT40 cells used in this study are listed in Supplementary
Table S1. Cells were cultured in RPMI1640 supplemented with 10%
fetal bovine serum, 1% chicken serum, 2 mM L-glutamine, 10 μM 2-
mercaptoethanol and 100 μg/mL kanamycin in 5% CO2 at 39 °C. DNA
transfection and RT-PCR were performed as previously described [22].
Drug-resistant colonies were selected in 96-well plates with medium
containing 1 mg/mL zeocin, 10 μg/mL mycophenolic acid, 0.5 μg/mL
puromycin, 30 μg/mL blasticidin, or 1 mg/mL L-histidinol. Gene disrup-
tion was veriﬁed by genomic PCR and RT-PCR. The primers used in RT-
PCR are listed in Supplemental Table S2. The targeting vectors for
RECQL5 gene disruption (based on pGEM-T Easy vector) are described
in Supplementary Figure S1A. Due to the low transfection efﬁciency,
each construct was digested with NdeI, and the linearized plasmids
were used for transfection. The expression vector for human RECQL5
was previously described [23].
2.2. Assessment of cell growth and sensitivity to DNA-damaging agents
Cell number was determined by ﬂow cytometry using plastic
microbeads and propidium iodide (PI). Cell solutions were mixed with
the plastic microbead suspension at a rate of 4: 1, and viable cellswere counted when a given number of microbeads were detected by
ﬂow cytometry. Cells not stained with PI were regarded as viable
cells. To assess drug sensitivity, approximately 1 × 104 cells were cul-
tured in 24-well plates containing various concentrations of DNA-
damaging agents in 1 mL of medium in duplicate. Cell viability was
assessed after 36–48 h by ﬂow cytometry using plastic microbeads
and PI (Liquid survival assay). The percent survival was determined by
considering the number of untreated cells as 100%. The ﬁnal concentra-
tion of PI was 1 μg/mL.2.3. Cell cycle analysis by ﬂow cytometry
For two-dimensional cell cycle analysis, cells were cultured inmedi-
um containing 1 μMCDDP and treated with 20 μMbromodeoxyuridine
(BrdU; BD Biosciences) for 20 min just before harvesting. Cells were
ﬁxed in 70% ethanol, treated with 0.5% (v/v) TritonX and 2.5 M HCl,
and stained with FITC-labeled anti-BrdU antibody (BD Biosciences)
and 1 μg/mL PI. Cell cycle distribution was analyzed by ﬂow cytometry.2.4. Detection of chromosome aberrations and sister chromatid exchange
To analyze chromosome aberrations, cells were cultured in the pres-
ence of 50 ng/mLMMC for 16 h and then treated with colcemid for the
last 135 min. Cells were harvested, treated with 75 mM KCl for 15 min,
and then ﬁxed withmethanol-acetic acid (3:1) for 30 min. The cell sus-
pension was dropped onto wet glass slides, air-dried, and stained with
3% Giemsa solution at pH 6.8 for 20 min and examined with a light mi-
croscope. To measure SCE, cells were cultured for two cycle periods in
medium containing 10 μM BrdU and then treated with colcemid for
the last 135 min. Cells were harvested and ﬁxed as described above.
To induce DNA damage, cells were treated with 200 nM CDDP for 8 h
just before harvesting. Differential stainingwasperformed as previously
described [24].2.5. Antibodies
The primary antibodies used were anti-chicken FANCD2 [25], anti-
Rad51 (a kind gift from Dr. Hitoshi Kurumizaka, Waseda University)
[26], anti-phospho-Chk1-Ser345 (Cell Signaling), anti-α-tubulin clone
DM1A (Sigma), anti-HA clone 3F10 (Roche Applied Science), and anti-
Histone H3 ab1791 (Abcam).2.6. Western blotting
Western blotting was carried out as previously described [27]. The
secondary antibodies used were horseradish peroxidase-conjugated
anti-rabbit, anti-rat, and anti-mouse IgG (Cell Signaling). Proteins
were visualized using ECL prime Western blotting detection reagents
(GE Healthcare). Images were captured with an ImageQuant LAS 3000
mini.2.7. Observation of subnuclear focus formation
After MMC exposure (500 ng/mL, 6 h or indicated periods), cells
were harvested and spun onto glass slides using a Cytospin. Cells were
ﬁxed with 4% paraformaldehyde, permeabilized with 0.1% (v/v) NP40
in PBS, and treatedwith anti-chicken FANCD2 or anti-Rad51 antibodies.
Alexa-Fluor 488 goat anti-rabbit IgG (Molecular Probes) was used as
secondary antibody and 0.1 μg/mL DAPI was used for counterstaining.
We only scored Rad51-foci positive and negative cells with non-
apoptotic nuclei. Images were captured with a ﬂuorescent microscope
(DM5500B; Leica and BZ-9000; KEYENCE).
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The rate of generation of surface IgM (sIgM) gain variants was moni-
tored as previously described [28]. Cells were treatedwith 250 nM CDDP
every other day, stained with R-Phycoerythrin (R-PE)-conjugated anti-
chicken IgM (Southern Biotech), and then analyzed by ﬂow cytometry.
2.9. Nucleotide sequence analysis of rearranged IgVλ segments derived
from sIgM-positive cells
Cell sorting was performed using the MiniMACS Starting Kit and
Anti-PE MicroBeads (Miltenyi Biotech). Cells were separated into sIgM-
positive and negative cell fractions, and genomic DNA for each sample
was extracted with PrepMan Ultra (Applied Biosystems). The sorted
cells were routinely tested for purity of enrichment by ﬂow cytometry
and sortingwas repeated until 90% ormore cellswere sIgM-positive. Nu-
cleotide sequence analysis was performed as described previously [28].
3. Results
3.1. RecQL5 is involved in ICL repair
To elucidate the cellular function of RecQL5, RECQL5 knock out (KO)
DT40 cells were generated using the CL18 subline as the parental
cell line. Gene targeting constructs designed to delete exons 3 and 4, in-
cluding helicase motif Ia, were sequentially transfected into DT40
CL18 cells. RECQL5 gene disruption was conﬁrmed by genomicFig. 1. ICL repair defect in RECQL5 KO cells. (A) Liquid survival assay. Cells were incubated for 48
standard deviation (SD). (B) Cell cycle analysis. Cell cycle distribution of cells treated with 1 μ
aberrations. Data are presented as the number of aberrations per 50 metaphases.PCR and RT-PCR (Supplementary Fig. S1). As previously reported
[12,24], lack of RECQL5 gene function did not affect cell growth (see
also Supplementary Fig. S5B).
To examine the involvement of RecQL5 in DNA repair, we initially
tested the sensitivity of RECQL5 KO cells to a variety of DNA-damaging
agents. RECQL5 KO cells were sensitive to the DNA-crosslinking agents
cisplatin (CDDP) and mitomycin C (MMC), whereas no sensitivity to
camptothecin (CPT), etoposide, hydroxyurea (HU), or X-raywas detected
compared with wild-type cells (Supplementary Fig. S2). Complementa-
tion of the CDDP and MMC sensitivity of RECQL5 KO cells by human
RECQL5-FLAG (Fig. 1A) indicated that the sensitivity was intrinsically
caused by the loss of RecQL5. Cell cycle distribution in response to
CDDP treatment was visualized by two-dimensional cell cycle analysis
using ﬂow cytometry. The proportion of cells in G1 and S phase was de-
creased, and that of cells in G2/M and subG1 phases, which corresponds
to dead cells, was increased in RECQL5 KO cells compared with wild-
type cells (Fig. 1B). Moreover, MMC-treated RECQL5 KO cells showed a
higher number of chromosome aberrations than wild-type cells
(Fig. 1C). The loss of factors such as FA proteins, which are involved in
ICL repair, leads to the induction of chromosome aberrations by MMC
treatment [15,29], suggesting that RecQL5 is involved in ICL repair.3.2. RecQL5 KO cells show Fanconi anemia pathway and replication
checkpoint activation
ICL repair is achieved through a complex mechanism that includes
several stages. To identify the speciﬁc stage of ICL repair in whichh inmedium containing cisplatin (CDDP) or mitomycin C (MMC). The error bars indicate
M CDDP was analyzed by ﬂow cytometry (left) and quantitated (right). (C) Chromosome
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known ICL repair-related reactions. First, to examine the involvement
of RecQL5 in the FA pathway, we generated RECQL5/FANCC double KO
cells (Supplementary Fig. S1C and S3A). FANCC is a component of the
FA core complex, and lack of FANCC causes a defect in the FA pathway
[16]. RECQL5/FANCC KO cells grew more slowly than either RECQL5 or
FANCC single KO cells (data not shown) and showed a higher proportion
of dead cells (Supplementary Fig. S3B). Furthermore, RECQL5/FANCC KO
cells showed higher sensitivity to CDDP than single mutants (Fig. 2A).
Monoubiquitinated FANCD2, which is detected as a slow-migrating
FANCD2 (FANCD2-L) band and is an indicator of FA pathway activation,
was present in RECQL5 KO cells but not in FANCC KO cells (Fig. 2B).
Moreover, efﬁcient FANCD2 focus formation was observed in the nuclei
of RECQL5 KO and wild-type cells (Fig. 2C). These results suggest that
the FA pathway is normally activated even in the absence of RecQL5.
Next, to examine the involvement of RecQL5 in the replication
checkpoint, we generated RECQL5/RAD17 double KO cells (Supplemen-
tary Fig. S1C and S4A). Rad17 promotes Chk1 phosphorylation, which is
a marker of replication checkpoint activation, in association with Rad9-
Rad1-Hus1, TopBP1, and ATR-ATRIP, whereas it does not affect the
monoubiquitination of FANCD2 [25,30]. RECQL5/RAD17KO cells showed
higher sensitivity to CDDP than single mutants (Supplementary
Fig. S4B). Moreover, phosphorylation of Chk1 was detected in RECQL5
KO cells in the presence of CDDP, similar towild-type cells (Supplemen-
tary Fig. S4C). These results suggest that activation of the replication
checkpoint occurs in the absence of RecQL5.
3.3. The function of RecQL5 in ICL-induced HR repair is dependent on BRCA2
Parallel to the FA pathway, Rad51, a key factor for HR, is recruited to
the ICL damage locus [31]. Rad51 interacts with RecQL5, as shown
in vivo and in vitro [6,10,11,32]; therefore, we analyzed the functionalFig. 2.Genetic analysis ofRECQL5mutation combinedwith FANCC. (A) Liquid survival assay. Cell
cisplatin (CDDP). The error bars indicate SD. (B) FANCD2monoubiquitination. Cells were treate
indicate ubiquitin-conjugated FANCD2 and FANCD2, respectively. (C) FANCD2-foci formation
panel, percentage of FANCD2-foci positive cells. The error bars indicate SD from two indepe
more than four bright foci were deﬁned as foci positive.relationship between RecQL5 and Rad51. One of the FA proteins,
FANCD1 (BRCA2), is required for Rad51-ﬁlament formation. Although
analysis of RAD51 KO cells is difﬁcult due to its lethality, BRCA2 gene
KO cells are viable and available for our experiments [33,34].We gener-
ated RECQL5/BRCA2 double KO cells (Fig. 3A) by using BRCA2−/+ cells
as the parental cell line [33], and converted these to BRCA2−/− null KO
cells by exposure to 4-hydroxy tamoxifen (OH-TAM) (Fig. 3A). After
re-cloning, BRCA2−/− and RECQL5−/−/BRCA2−/− cells were selected
by RT-PCR (Supplementary Fig. S5A). RECQL5−/−, BRCA2−/+, and
RECQL5−/−/BRCA2−/+ cells showed the same proliferative capacity as
wild-type cells, whereas BRCA2−/− cells had a lower proliferative capac-
ity. RECQL5−/−/BRCA2−/− cells showed a low proliferative capacity sim-
ilar to that of BRCA2−/− cells (Supplementary Fig. S5B). RECQL5−/−/
BRCA2−/+ cells were more sensitive to CDDP than BRCA2−/+ cells, and
BRCA2−/− and RECQL5−/−/BRCA2−/− cells were more sensitive than
RECQL5−/−/BRCA2−/+ cells (Fig. 3B). Importantly, the sensitivities of
BRCA2−/− and RECQL5−/−/BRCA2−/− cells were almost the same. This
phenotype of RECQL5/BRCA2 KO cells is obviously different from that
of RECQL5/FANCC or RECQL5/RAD17 KO cells, suggesting that RecQL5
works in the same pathway as BRCA2, but in different pathways as
FANCC and RAD17.
As reported, Rad51-foci representing chromatin loading were
strongly induced by MMC treatment in wild-type cells [26] but not in
BRCA2−/− cells (Fig. 3C). Under the same conditions, Rad51-foci were
observed in RECQL5−/− cells but not in RECQL5−/−/BRCA2−/− cells
(Fig. 3C). These results indicated that Rad51 chromatin loading after
damage induction occurred in a BRCA2-dependent manner regardless
of the presence or absence of RecQL5. This speculation was conﬁrmed
by an increase in Rad51 association to chromatin upon MMC treatment
in wild-type and RECQL5−/− cells that was not observed in BRCA2−/−
and RECQL5−/−/BRCA2−/− cells (Supplementary Fig. S5C). Moreover,
the increased incidence of SCE, which is an indicator of post-swere incubated for 48 h inmedium containing high (left) or low (right) concentrations of
d with 500 ng/mL mitomycin C (MMC) for 6 h and analyzed byWestern blotting. L and S
. Upper panel, images of cells treated or not treated with 500 ng/mL MMC for 6 h. Lower
ndent experiments. At least 100 nuclei were scored in each case, and nuclei containing
Fig. 3.Genetic analysis of RECQL5mutation combinedwith BRCA2. (A) Schematic representation of the gene targeting procedure. Cells were cloned after treatmentwith 20 nM4-hydroxy
tamoxifen (OH-TAM) for 2 days. (B) Liquid survival assay. Cells were incubated for 48 h inmedium containing cisplatin (CDDP). The error bars indicate SD. (C) Rad51-foci formation. Left
panel, images of cells treated or not treated with 500 ng/mL mitomycin C (MMC) for 6 h. Right panel, percentage of Rad51-foci positive cells. The error bars indicate SD from two inde-
pendent experiments. At least 200 nuclei were scored in each case, and nuclei containing more than four bright foci were deﬁned as foci positive. (D) Histograms of SCE. Numbers rep-
resent mean of scores from 50 metaphases. P values were calculated by Student's t-test.
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ment was almost abolished in BRCA2−/− cells (Fig. 3D). RECQL5−/−/
BRCA2−/+ cells exhibited a slight increase of CDDP-induced SCE com-
pared with BRCA2−/+ cells (Fig. 3D left). Spontaneous and CDDP-
induced SCE were barely detected in RECQL5−/−/BRCA2−/− and BRCA2
−/− cells (Fig. 3D right). AsRECQL5 andBRCA2have an epistatic relation-
ship with regard to ICL repair (Fig. 3B), the data of Fig. 3C and D suggest
that RecQL5 is involved in ICL-induced HR repair in association with
BRCA2. Additionally, we examined the signiﬁcance of the interaction
between RecQL5 and Rad51 for ICL repair. It was previously revealed
that human RecQL5-T668A mutant attenuated to bind to Rad51 [10].
We generated RECQL5−/− cells expressing human RecQL5-T668A, and
assayed the sensitivity of the cells to CDDP. The expression of the
human RecQL5-T668A mutant did not complement the CDDP sensitivi-
ty caused by loss of RecQL5 (Supplementary Fig. S6). This result suggests
that the interaction between RecQL5 and Rad51 is important for the
function of RecQL5 in ICL repair.
3.4. RecQL5 functions in a relatively late step of ICL repair
Monoubiquitination of FANCD2, Chk1 phosphorylation, and Rad51-
focus formation were normally induced at relatively early time pointsafter exposure to ICL agents in RECQL5 KO cells, similar to wild-type
cells (Figs. 2B, 3C and Supplementary Fig. S4C), indicating that the
absence of RecQL5 has little impact on the early steps of ICL repair. We
next examined the effect of lack of RecQL5 on the late steps of ICL repair
bymonitoring phenomena that occur during the late stages of the dam-
age response after MMC treatment (Fig. 4A). In RECQL5 KO cells, the
timing of the appearance of Rad51-foci in response to MMC treatment
was similar to that of wild-type cells (Fig. 4B, 0–8 h). By contrast, the
disappearance of Rad51-foci was delayed in RECQL5 KO cells compared
with wild-type cells (Fig. 4B, 8–36 h). At these time points, the propor-
tion of viable cells was more than 60% (Supplementary Fig. S7), and
apparently dead cells having apoptotic nuclei were not scored. Thus, it
is likely that the persistent Rad51-foci phenotype reﬂects the phenom-
enon in viable cells. The sustained presence of Rad51-foci in RECQL5 KO
cells uponMMC exposure has two possible explanations. One is that the
amount of DNA damage caused by ICL-inducing agents is increased to a
greater extent in RECQL5 KO cells than in wild-type cells, leading to the
prolonged existence of Rad51-foci. The other possibility is that RecQL5
is necessary for the late step of ICL repair. If the former is correct,
RECQL5/BRCA2 KO cells would be expected to exhibit higher sensitivity
to ICL damage than RECQL5KO cells because the increased DNA damage
caused by the absence of RecQL5 may be repaired by HR involving
Fig. 4. Change of DNA damage signals in cells. (A) Schematic representation of sampling
time after mitomycin C (MMC) (500 ng/mL) exposure. (B) Rad51-foci formation. Upper
panel, images of cells treated with MMC. Lower panel, time course of the appearance of
Rad51-foci positive cells. The error bars indicate SD from two independent experiments.
At least 200 nuclei were scored in each case, and nuclei containing more than four bright
foci were deﬁned as foci positive.
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BRCA2 KO cells and BRCA2 KO cells (Fig. 3B), we suggest the latter
possibility to be more likely.
3.5. Loss of both RecQL5 and Rad54 causes hypersensitivity to ICL agents
and Rad51-foci accumulation
Rad54 functions after Rad51-ﬁlament formation in HR repair [36].
Because RecQL5 displaces Rad51 from the Rad51-ﬁlament in vitro, it is
interesting to examine RECQL5/RAD54 double KO phenotypes. For this
purpose,we generated RECQL5/RAD54double KO cells using conditional
RAD54 KO cells (RAD54−/− + hRAD54-HA cells) as the parental cell line
[37], in which expression of human RAD54-HA protein is suppressed by
doxycyclin (Dox) treatment, because of the possibility of synthetic le-
thality (Fig. 5A). The disruption of both alleles of the RECQL5 gene in
RAD54−/− + hRAD54-HA cells was conﬁrmed by assessing for the dis-
appearance of RECQL5mRNA (Supplementary Fig. S8A). The disappear-
ance of hRad54-HA proteins after Dox treatment was veriﬁed with an
anti-HA tag antibody (Supplementary Fig. S8B). RECQL5/RAD54 KO
cells did not show synthetic lethality, but grew at a slower rate than ei-
ther RECQL5 or RAD54 single KO cells (Supplementary Fig. S8C). Cell
cycle analysis demonstrated that RECQL5/RAD54 KO cells had a tenden-
cy to accumulate in G2/M phase (Supplementary Fig. S8D). RECQL5/
RAD54 KO cells showed higher sensitivity to CDDP than the singlemutants (Fig. 5B). In addition, spontaneously formed Rad51-foci
showed a greater increase in RECQL5/RAD54 KO cells than in each single
mutant, which had more spontaneous Rad51-foci than wild-type cells
(Fig. 5C). Moreover, the disappearance of MMC-induced Rad51-foci
was slower in RECQL5/RAD54 KO cells than in RECQL5 or RAD54 single
KO cells (Fig. 5D), suggesting that RecQL5 and RAD54 work in parallel
pathways to regulate RAD51 ﬁlament disassembly.
3.6. RecQL5 controls the frequency and variation of CDDP-induced gene
conversion in the IgVλ locus
In DT40 cells, HR-mediated gene conversion constitutively occurs at
the immunoglobulin V gene locus in a process referred to as immuno-
globulin gene conversion (IgGC) [38,39]. IgGC uses one of 25 pseudo V
(ΨV) gene segments located upstream of the V gene as a donor tem-
plate for recombination between the DNA sequence and the V gene,
resulting in immunoglobulin diversiﬁcation (Fig. 6A). The cell line
used in this study, CL18, does not express surface IgM (sIgM) on the
cellmembrane because of a frameshiftmutation at the V locus in the im-
munoglobulin light chain (Vλ) (Fig. 6A and Supplementary Fig. S1C).
Removing this frameshift mutation by IgGC leads to expression of
sIgM on the cell membrane. Surface IgM− to IgM+ conversion is called
sIgM+ gain, which is mainly caused by IgGC. Therefore, the frequency
of IgGC can be determined indirectly by measuring the proportion of
sIgM-positive cells. Interestingly, loss of BLM, another RecQ helicase, re-
sults in a decrease in IgGC frequency in DT40 cells [40]. On the other
hand, loss of WRN or BLM leads to an increase in the frequency of
class-switch recombination end joining in human B cells [41], indicating
that RecQ helicases somehow regulate recombination at the Ig locus.
We ﬁrst examined the effect of RecQL5 on the frequency of IgGC.
Cells were cultured for 30 days under non-perturbed conditions, and
then sIgM+ gain was measured with 24 subclones. Under the non-
perturbed condition, there was little difference in the average sIgM+
gain between wild-type and RECQL5 KO cells (Fig. 6B left). However,
sIgM+ gain was 6.5-fold higher in RECQL5 KO cells than in wild-type
cells after culture for 8 days in the presence of CDDP (Fig. 6B right). Im-
portantly, sIgM+gainwas not apparently induced by CDDP inwild-type
cells (Fig. 6C). These results suggest that RecQL5 suppresses CDDP-
induced IgGC. The increase of CDDP-induced sIgM+ gain by the absence
of RecQL5 is a novel phenotype that has never been reported in any
other DT40 mutants.
Deamination of cytosine on the Ig V gene locus by activation-
induced cytidine deaminase (AID) induces spontaneous IgGC [42].
Therefore, we determined whether CDDP-induced IgGC in RECQL5 KO
cells is dependent on the function of AID. We generated RECQL5/AID
double KO cells (Supplementary Fig. S1C and S9A), conﬁrmed that the
sensitivity to CDDP in RECQL5/AID KO cells was the same as that in
RECQL5 KO cells (Supplementary Fig. S9B) and measured the frequency
of sIgM+ gain. In RECQL5/AID KO cells, the frequency of sIgM+ gain was
not increased by CDDP (Fig. 6C), suggesting that CDDP-induced IgGC in
the absence of RecQL5 depends on AID function.
In addition tomeasuring the frequency of IgGC, nucleotide sequence
analysis of the IgVλ locus in sIgM-positive cells provides information
about the variation of IgGC. We therefore analyzed the nucleotide
sequence at the IgVλ locus in sIgM-positive cells. In CL18 cells, one
nucleotide is inserted in complementary-determining region 1 (CDR1)
to generate a frameshift mutation, and sIgM− to sIgM+ conversion
occurs by removing this insertion through IgGC (Fig. 6A). ΨV8, one of
25 ΨV gene segments, has the highest homology to the locus of the
Vλ gene containing the insertion [43]. Therefore, ΨV8 is the most
frequently used donor template for IgGC among theΨV gene segments.
Under non-perturbed conditions, theΨV8 segmentwas used in 100% of
the IgGC events in both wild-type and RECQL5 KO cells (Fig. 6D left). By
contrast, in the presence of CDDP, the usage ofΨV segments other than
ΨV8 was increased to 22.4% in wild-type cells (Fig. 6D right), although
IgGC was not increased by CDDP in wild-type cells (Fig. 6B and C).
Fig. 5.Genetic analysis of RECQL5mutation combinedwith RAD54. (A) Schematic representation of the gene targeting procedure. Cells were used after treatmentwith 1 μg/mL doxycyclin
(Dox) for 5 days. (B) Liquid survival assay. Cells were incubated for 48 h in medium containing cisplatin (CDDP). The error bars indicate SD. (C) Spontaneous Rad51-foci formation. The
error bars indicate SD from three independent experiments. At least 250 nuclei were scored in each case, and nuclei containing more than four bright foci were deﬁned as foci positive.
P values were calculated by Student's t-test. (D) Mitomycin C (MMC)-induced Rad51-foci formation. Cells were treated with MMC and washed as described in the ﬁgure legend for
Fig. 4A, and then harvested at the indicated time points. The plots represent mean and SD from two independent experiments. At least 200 nuclei were scored in each case, and nuclei
containing more than four bright foci were deﬁned as foci positive.
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ΨV8 in RECQL5 KO cells (Fig. 6D right), indicating that the donor usage
was signiﬁcantly diversiﬁed in RECQL5 KO cells. These results suggest
that RecQL5 regulates the frequency and variation (quality) of CDDP-
induced IgGC.
4. Discussion
4.1. Role of RecQL5 in ICL repair
In the present study, we showed that RECQL5 gene KO chicken DT40
cells showed speciﬁc sensitivity to the ICL damage-inducing agents
CDDP and MMC. These results are in agreement with a previous study
showing that RECQL5 mutants of Drosophila melanogaster were more
sensitive to CDDP than wild-type ﬂies [32]. Moreover, RecQL5-foci
formed after CDDP treatment co-localize with PCNA in human HeLa
cells [9] and RecQL5 was reported to participate in psoralen induced
ICL repair in human cells [44]. Taking into account the analyses of func-
tion of RecQL5 in ﬂy [32], human [9,44], and chicken (this study),
RecQL5 seems to function in ICL repair in many species.
The data presented in this study indicated that the function of RecQL5
in ICL-induced DNA repair is dependent on BRCA2, whereas the
monoubiquitination of FANCD2 is performed by FA core-associated pro-
teins (Figs. 2 and 3). The FANCN and FANCO gene products, PALB2 and
Rad51C, associatewith BRCA2, and formation of Rad51-foci is suppressedby the lack of PALB2 or Rad51C [21,45]. By contrast, Rad51-foci were
efﬁciently formed and their disappearance was markedly delayed in the
absence of RecQL5 (Fig. 4B), suggesting that RecQL5 functions in the
step of ICL repair after Rad51-ﬁlament formation. Rad54 and the recently
identiﬁed Mcm8–Mcm9 complex are also involved in the step of ICL re-
pair after Rad51-ﬁlament formation [26,36]. However, ICL-induced re-
combination was increased in RECQL5 KO cells (Figs. 3D and 6B),
whereas various ICL repair-related geneKO cells such as FA core complex,
Rad51 paralogs, Rad54, and Mcm8–Mcm9 reportedly show decreased
ICL-induced recombination [16,26,36]. Taken together, these data indi-
cate that RecQL5 negatively regulates recombination during ICL repair.
Recently, a mechanism of ICL repair was proposed by analyzing
a cell-free ICL repair system using Xenopus egg extracts and ICL-
containing plasmids [31,46,47]. The proposed model of replication-
coupled ICL repair is as follows (Fig. 7A): (i) dual replication forks ap-
proach and arrest at ICL sites, and RPA binds a ssDNA gap on the lagging
strand; (ii) Rad51 is recruited to RPA coated ssDNA before DSB forma-
tion by nucleolytic incision; (iii) the ID complex is monoubiquitinated,
which may recruit nucleases SLX4 and XPF to unhook the ICL and
allow TLS to occur; (iv) the DNAwith a double-strand break is repaired
by HR using a sister chromatid. In the present study, we aimed to deter-
mine the recombination step in ICL repair in which RecQL5 is involved.
Our data indicate that RecQL5 functions after Rad51-ﬁlament formation.
Furthermore, in prior studies, biochemical analyses have suggested that
RecQL5 can dissociate Rad51 from the Rad51-ssDNAﬁlament, inhibiting
Fig. 6.Analysis of IgGC events at the light chain locus. (A) Schematic representation of sIgM− to sIgM+ conversion. The detail is described in the text. (B) Fluctuation analysis of sIgM+ gain.
Cells were subcloned by limiting dilution (n = 24 for each genotype) and kept in culture in the absence of cisplatin (CDDP) for 30 days (left) or in the presence of CDDP for 8 days (right)
after subcloning. Diamonds represent percentage of sIgM-positive cells in each clonal subpopulation. Lines and numbers indicate mean of % of sIgM+ gain. P values were calculated by
Student's t-test. NS, statistically not signiﬁcantly different. (C) Time course of sIgM+ gain. Cells were cultured inmedium containing CDDP and the proportion of sIgM+ cells wasmeasured
at the time indicated. The error bars indicate SD from two independent experiments. (D)Usage ofΨV genes as a donor for IgGC. Surface IgM-positive fractionswere isolated formcells used
in Fig. 6B, and the nucleotide sequences of rearranged Vλ genes were analyzed. The total number of Vλ sequences analyzed is indicated in the center of the charts.
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RecQL5 acts on the Rad51-ﬁlament before strand invasion (pre-synaptic
ﬁlament) rather than the ﬁlament acting on the D-loop (post-synaptic
ﬁlament). According to the model, two pre-synaptic ﬁlaments are as-
sumed to be possible targets of RecQL5 (Fig. 7A). One is the Rad51-
ﬁlament formed on the DNA possessing crosslink, which inhibits exten-
sion of DNA synthesis after TLS. RecQL5 may function to disrupt the
Rad51-ﬁlament and promote DNA synthesis. Another possible target
is twin Rad51-ﬁlament formed on DNA with DSBs. When one Rad51-
ﬁlament invades a sister chromatid and forms a D-loop structure, anoth-
er Rad51-ﬁlament that is simultaneously formed is unnecessary for the
repair process and becomes harmful. RecQL5 may prevent the forma-
tion of intricate recombination intermediates by removing the unneces-
sary Rad51-ﬁlament. Although these possibilities are not mutually
exclusive, we prefer the latter explanation. If another Rad51-ﬁlament
is retained because of loss of RecQL5 function, a double Holliday junc-
tion (dHJ) is subsequently formed by second end capture or strand inva-
sion to a chromatid other than the sister chromatid containing
homologous sequences is induced, leading to a decrease of DNA repair
efﬁciency and an increase of improper recombination (Fig. 7B). This in-
terpretation is not in conﬂict with the increase of SCE and chromosome
aberrations in RECQL5 KO cells (Figs. 1C and 3D).4.2. RecQL5 and Rad54 act on different aspects of the Rad51-ssDNA
ﬁlament
Rad54 plays a role in HR after pre-synaptic ﬁlament formation to
help strand invasion of the Rad51-ﬁlament and to promote branch
migration at the D-loop [36]. Since these functions are defective in
RAD54 KO cells, it is likely that RAD54 KO cells show decreased ICL re-
pair ability and increased Rad51-foci formation associated with the
accumulation of pre-synaptic ﬁlament. Previously, BRCA2/RAD54
double KO cells showed high sensitivity to CDDP similar to BRCA2
KO cells [33], implying that Rad54 functions after BRCA2 dependent
Rad51-ﬁlament formation in ICL repair. We found that RECQL5/
RAD54 double KO cells were more sensitive to CDDP and accumulat-
ed more Rad51-foci than single KO cells (Fig. 5). These phenotypes
can be explained by the defects in Rad54 function described above
and the removal of unnecessary Rad51-ﬁlament by RecQL5 as described
in the previous section. Interestingly, KU70 KO DT40 cells defective in
non-homologous end joining (NHEJ) show similar sensitivity to CDDP
to that of wild-type cells, whereas RAD54/KU70 double KO cells show
higher sensitivity than RAD54 single KO cells [48]. This ﬁnding suggests
that someDSBs formed during ICL repair are repaired byNHEJ to comple-
ment the defect of HR resulting from the loss of Rad54 (Supplementary
Fig. 7.Model of ICL repair including RecQL5. The detail is described in the Discussion section.
1010 Y. Hosono et al. / Biochimica et Biophysica Acta 1843 (2014) 1002–1012Fig. S10). RecQL5 might play a role in canceling HR by destroying the
pre-synaptic ﬁlament, whose processing is difﬁcult in RAD54 KO cells,
and promoting NHEJ or other repair pathway. Alternatively, the loss ofRecQL5 could induce transcription-associated recombination [49,50]
by creating a CDDP-dependent transcription block, and accumulation
of excessive recombination intermediates in RECQL5/RAD54 double KO
1011Y. Hosono et al. / Biochimica et Biophysica Acta 1843 (2014) 1002–1012cells could cause cell toxicity. These possibilitieswill be investigated in a
future study.
4.3. Relation between RecQL5 function and cancer
In the present study, we showed that donor usage in CDDP-induced
IgGC was diversiﬁed in RECQL5 KO cells (Fig. 6D), suggesting that
RecQL5 affects the quality of recombination by suppressing the usage of
a low homology locus as the donor. Although the result concerning
IgGC in the Ig locus does not necessarily extend to whole genome events,
it may be associated with the cancer predisposition phenotype of Recql5
KOmice [6,7] if the endogenous ICL damage is processed by RecQL5. Re-
cent studies showed that FA proteins function in damage tolerance to
formaldehyde and acetaldehyde [51–55], which are generated in the
cell and cause ICL and DNA-protein crosslinks. Therefore, RecQL5 may
contribute to the repair of aldehyde-induced ICL damage, similar to FA
proteins.
In summary, our systematic analyses using DT40 cells suggest that
RecQL5 controls the frequency and quality of ICL-induced recombina-
tion to prevent genome instability. Although no clinical syndrome has
been associatedwith defects in RECQL5 up to present, it is not surprising
if Bloom syndrome-like or Fanconi anemia-like genetic disease will be
found, which is caused by the abnormality of RecQL5. RecQL5 was
found to be overexpressed in mesothelioma in association with resis-
tance to carboplatin, a platinum-containing drug [56]. RecQL5 could
be involved in themechanism of tolerance to carboplatin by promoting
ICL repair in mesothelioma, in which case the down-regulation of
RecQL5 expressionmay provide information to counteract the tolerance
to ICL agents. Elucidation of the function of RecQL5 could shed light on
the mechanisms of tumorigenesis and thus help overcome the drug
resistance of tumor cells.
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